Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 May;16(5):102464.
doi: 10.1016/j.dsx.2022.102464. Epub 2022 Mar 18.

The prognostic values of thyroid disorders in predicting COVID-19 composite poor outcomes: A systematic review and meta-analysis

Affiliations
Meta-Analysis

The prognostic values of thyroid disorders in predicting COVID-19 composite poor outcomes: A systematic review and meta-analysis

Hikmat Permana et al. Diabetes Metab Syndr. 2022 May.

Abstract

Background and aims: In this meta-analysis, we aimed to evaluate the prognostic properties of thyroid disorder during admission on poor prognosis and factors that may influence the relationship in patients with COVID-19.

Methods: A systematic literature search of PubMed, EBSCO, and CENTRAL was conducted from inception to August 27, 2021. The main exposure was unspecified and specified thyroid disorders-hypothyroidism or hypothyroidism. The outcome of interest was the COVID-19 composite poor outcome that comprises of severity, mortality, ICU admission, and hospitalization.

Results: There were 24,734 patients from 20 studies. Meta-analysis showed that thyroid disorder was associated with composite poor outcome (OR 2.87 (95% CI 2.04-4.04), p < 0.001; I2 = 62.4%, p < 0.001). Meta regression showed that age (p = 0.047) and hypertension (p = 0.01), but not gender (p = 0.15), DM (p = 0.10), CAD/CVD (p = 0.38), obesity (p = 0.84), and COPD (p = 0.07) affected the association. Subgroup analysis showed that thyroid disorder increased risk of severe COVID-19 (OR 5.13 (95% CI 3.22-8.17), p < 0.05; I2 = 0%, p = 0.70) and mortality (OR 2.78 (95%CI 1.31-5.90), p < 0.05; I2 = 80%, p < 0.01). Pooled diagnostic analysis of thyroid disorder yielded a sensitivity of 0.22 (0.13-0.35), specificity of 0.92 (0.87-0.95), and AUC of 0.72. The probability of poor outcome was 38% in patients with thyroid disorder and 15% in patients without thyroid abnormality.

Conclusion: On-admission thyroid disorder was associated with poor prognosis in COVID-19 patients.

Keywords: COVID-19; Hypothyroidism; Prognosis; Thyroid disorder.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that there is no conflict of interest.

Figures

Fig. 1
Fig. 1
PRISMA literature search flowchart.
Fig. 2
Fig. 2
Pooled sensitivity and specificity of thyroid disorders for COVID-19 poor outcomes.
Fig. 3
Fig. 3
Summary receiver operating characteristics (SROC) of thyroid disorders for COVID-19 composite poor outcome.
Fig. 4
Fig. 4
Fagan's nomogram analysis elucidating the post-test probability of the presence of thyroid disorders in predicting COVID-19 poor outcomes.

References

    1. Gao Z., Xu Y., Sun C., Wang X., Guo Y., Qiu S., et al. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. 2021;54(1):12–16. - PMC - PubMed
    1. Chung J.Y., Thone M.N., Kwon Y.J. COVID-19 vaccines: the status and perspectives in delivery points of view. Adv Drug Deliv Rev. 2021;170:1–25. - PMC - PubMed
    1. Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141–154. - PMC - PubMed
    1. Malik P., Patel U., Mehta D., Patel N., Kelkar R., Akrmah M., et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med. 2020 - PMC - PubMed
    1. Soetedjo N.N.M., Iryaningrum M.R., Damara F.A., Permadhi I., Sutanto L.B., Hartono H., et al. Clinical Nutrition ESPEN; 2021. Prognostic properties of hypoalbuminemia in COVID-19 patients: a systematic review and diagnostic meta-analysis. - PMC - PubMed